{
    "organizations": [],
    "uuid": "8d5ee51d60c77290c1e7c3bfb33837212505998a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-resverlogix-announces-proposed-off/brief-resverlogix-announces-proposed-offering-of-units-idUSASC09W4G",
    "ord_in_thread": 0,
    "title": "BRIEF-Resverlogix Announces Proposed Offering Of Units",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - Resverlogix Corp:\n* RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS * RESVERLOGIX - OFFERINGâ€™S PROCEEDS TO FUND RESEARCH & DEVELOPMENT OF CLINICAL TRIAL ACTIVITIES RELATED TO PHASE 3 BETONMACE TRIAL, AMONG OTHERS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-17T21:14:00.000+03:00",
    "crawled": "2018-04-18T18:06:13.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "resverlogix",
        "corp",
        "resverlogix",
        "announces",
        "proposed",
        "offering",
        "unit",
        "resverlogix",
        "offering",
        "proceeds",
        "fund",
        "research",
        "development",
        "clinical",
        "trial",
        "activity",
        "related",
        "phase",
        "betonmace",
        "trial",
        "among",
        "others",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}